Nice Fortune article, so I don't understand why there is not some activity on share price. Googled the CEO - to me he does not appear to have a great track record. Then thinking of the process; ultrasound / cavitation. Wondering how cells aren't damaged using a process that would seem so violent on a microscopic level. Then there's the balance sheet. Really would like to buy in if I could see some promise along with better leadership. Let's face it, this stock is cheap - but zero is even cheaper. Can anyone help explain these anomalies?
Positive and there have been a lot of positives listed and brought out about these procedures, both current and potential. Still it seems they are having a hard time sustaining or generating a steady or at least gradually building volume in the stock. Maybe this is partially because they still have that pesky .pk but it would be nice to see a buildup. It certainly seems like if everything is as it is purported to be, this should be a company on the move?